Clinical Trials Directory

Trials / Unknown

UnknownNCT04414735

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Fundacion Clinic per a la Recerca Biomédica · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to evaluate the superiority of photopheresis in combination with the standard immunosuppression vs standard immunosuppression alone for the prevention of acute rejection in highly sensitized kidney transplant recipients (cPRA ≥90%). Unicentric, randomized, open study.

Conditions

Interventions

TypeNameDescription
OTHERExtracorporeal PhotopheresisInfusion of autologous cellular products exposed to ultraviolet light (UV), in the presence of a photosensitizer. The cellular product is obtained through leucopheresis and its subsequent exposure to 8-methoxypsoralen (8-MOP) and irradiation with UV-A light.

Timeline

Start date
2022-08-17
Primary completion
2025-03-01
Completion
2025-12-01
First posted
2020-06-04
Last updated
2023-07-06

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04414735. Inclusion in this directory is not an endorsement.